Kenneth R. Deans Jr.
South Carolina
Kenneth R. Deans Jr. is a Contributing Writer for The American Quorum. With 30+ years of leadership across healthcare, technology, and education, he brings an experienced, independent perspective to issues shaping America.
Healthcare
Delta Variant Reaches 83% of U.S. COVID-19 Cases as Hospitalizations Rise and Low-Vaccination Regions Drive the Surge
Tech
Blue Origin Flies Bezos, Funk and First Paying Customer Past the Kármán Line in New Shepard’s First Human Mission
Healthcare
U.S. COVID-19 Cases Jump Nearly 70% in a Week as Delta Drives a ‘Pandemic of the Unvaccinated’
Tech
Virgin Galactic Carries Richard Branson to Space in First Full-Cabin Flight, Moving Commercial Space Tourism Closer to Service
Healthcare
Pfizer Plans U.S. Booster Filing as CDC and FDA Say Fully Vaccinated Americans Do Not Need a Third Shot Yet
Tech
Pentagon Cancels $10 Billion JEDI Cloud Contract and Opens New Multi-Cloud Competition
Healthcare
U.S. Falls Short of 70% Adult Vaccination Goal as Delta Expands and First-Dose Growth Slows
Tech
FINRA Orders Robinhood to Pay Nearly $70 Million, Its Largest-Ever Financial Penalty
Healthcare
CDC Advisers Say mRNA Vaccine Benefits Still Outweigh Myocarditis Risk as Cases Cluster in Younger Men
Tech
Microsoft Unveils Windows 11 With Android Apps, Teams Integration and a New Hardware Security Baseline
Healthcare
U.S. Reaches 300 Million COVID-19 Shots in 150 Days as Adult Vaccination Hits 65% and Delta Raises New Risk
Tech
Biden Names Lina Khan FTC Chair After 69-28 Senate Confirmation, Putting Big Tech Critic at Center of Antitrust Push
Healthcare
FDA Approves Aduhelm for Alzheimer’s Through Accelerated Pathway Despite Conflicting Clinical Evidence
Tech
Apple’s WWDC Pushes iOS 15, Monterey, iCloud+ Privacy and Xcode Cloud Across a Platform of More Than 30 Million Developers
Healthcare
U.S. Sets First Global Vaccine-Sharing Plan, Sending 25 Million Doses Abroad With 75% Routed Through COVAX
Tech
Facebook Sets Trump Suspension at Two Years and Rewrites Rules for Politicians After Oversight Board Rebuke
Healthcare
Moderna Reports 100% Observed Efficacy in TeenCOVE Trial and Plans FDA Filing for Ages 12 to 17
401 stories